Based in Riom in the Puy-de-Dôme region, Verdot IPS² designs and manufactures a complete range of purification equipment for the biopharmaceutical, pharmaceutical, cosmetology, and food processing industries (primarily chromatography columns and skids). This technology is critical for the development and production of active ingredients for drugs, vaccines, and biotechnological products. Its clients are primarily major players in the pharmaceutical industry (Top 10 Big Pharma companies & subcontractors, as well as French and international biotech firms).
Very few players worldwide master this cutting-edge technology and are capable of meeting the highly stringent regulatory requirements for pharmaceutical product certification processes. The company has successfully developed unique expertise, know-how, and agility in responding to complex tenders (custom-made equipment) and managing production lead times, a fundamental asset in the current context of intense demand.
With average annual growth of 15% since 2015, Verdot IPS² will achieve sales of around €13.5 million in 2020, of which almost 90% will be generated internationally, and employs 40 staff, including nearly 20 engineers. With the support of Capital Export, Verdot IPS²'s strategy is to pursue the development of its product range and accelerate its international deployment, particularly in China and North America, while maintaining its efforts in sectoral diversification.
Capital Export will also support its new investment in deepening its ESG policy. This initiative is an integral part of the company’s strategy, which is already well advanced in implementing and monitoring non-financial issues (training, quality, human resources safety, resource utilization, and environmental impact).
.png)
